Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enric Carreras

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Transplantation|April 29, 2004
Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective studyMontserrat Rovira, Mónica Jimenéz, Jorge Puig De La Bellacasa, et al.
Expert Opinion on Drug Safety|December 12, 2012
Drug safety evaluation of defibrotidePaul G Richardson, Selim Corbacioglu, Vincent Trien-Vinh Ho, et al.
Frontiers in Immunology|January 23, 2026
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adultsGorka Pinedo, María Suárez-Lledó, Maite Antonio, et al.
Haematologica|October 5, 2006
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantationMiquel Granell, Alvaro Urbano-Ispizua, Juan Ignacio Aróstegui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignanciesPere Barba, David Valcárcel, José Antonio Pérez-Simón, et al.
Frontiers in Immunology|October 26, 2019
Acute Graft-vs.-Host Disease-Associated Endothelial Activation <i>in vitro</i> Is Prevented by DefibrotideJulia Martinez-Sanchez, Hannah Hamelmann, Marta Palomo, et al.
European Journal of Haematology|March 31, 2011
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopeniaCarlos Cervera, Francesc Fernández-Avilés, Oscar de la Calle-Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 12, 2016
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use ProgramSelim Corbacioglu, Enric Carreras, Mohamad Mohty, et al.
Annals of Hematology|November 13, 2023
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational studyMarc Brusosa, Sonia Ruiz, Inés Monge, et al.
Hematology, Transfusion and Cell Therapy|October 27, 2023
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide eraMaría Queralt Salas, Luis Gerardo Rodríguez-Lobato, Paola Charry, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Transplantation|April 29, 2004
Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective studyMontserrat Rovira, Mónica Jimenéz, Jorge Puig De La Bellacasa, et al.
Expert Opinion on Drug Safety|December 12, 2012
Drug safety evaluation of defibrotidePaul G Richardson, Selim Corbacioglu, Vincent Trien-Vinh Ho, et al.
Frontiers in Immunology|January 23, 2026
Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adultsGorka Pinedo, María Suárez-Lledó, Maite Antonio, et al.
Haematologica|October 5, 2006
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantationMiquel Granell, Alvaro Urbano-Ispizua, Juan Ignacio Aróstegui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 12, 2013
Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignanciesPere Barba, David Valcárcel, José Antonio Pérez-Simón, et al.
Frontiers in Immunology|October 26, 2019
Acute Graft-vs.-Host Disease-Associated Endothelial Activation <i>in vitro</i> Is Prevented by DefibrotideJulia Martinez-Sanchez, Hannah Hamelmann, Marta Palomo, et al.
European Journal of Haematology|March 31, 2011
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopeniaCarlos Cervera, Francesc Fernández-Avilés, Oscar de la Calle-Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 12, 2016
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use ProgramSelim Corbacioglu, Enric Carreras, Mohamad Mohty, et al.
Annals of Hematology|November 13, 2023
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational studyMarc Brusosa, Sonia Ruiz, Inés Monge, et al.
Hematology, Transfusion and Cell Therapy|October 27, 2023
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide eraMaría Queralt Salas, Luis Gerardo Rodríguez-Lobato, Paola Charry, et al.
Pageof 15